flutamide has been researched along with Di Guglielmo Disease in 2 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with androstenedione (500nM) significantly (p<0." | 1.29 | Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells. ( Halushka, PV; Higashiura, K; Mathur, RS; Zucker, TP, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ajayi, AA | 1 |
Matsuda, K | 1 |
Schrör, K | 1 |
Masuda, A | 1 |
Mathur, R | 1 |
Halushka, PV | 2 |
Zucker, TP | 1 |
Higashiura, K | 1 |
Mathur, RS | 1 |
2 other studies available for flutamide and Di Guglielmo Disease
Article | Year |
---|---|
Androgen regulation of thromboxane A2 receptors.
Topics: Animals; Aorta; Blood Platelets; Cells, Cultured; Estradiol; Flutamide; Humans; Kinetics; Leukemia, | 1995 |
Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells.
Topics: Androgen Antagonists; Androstenedione; Animals; Aorta; Bridged Bicyclo Compounds, Heterocyclic; Carb | 1996 |